| |
| | note on Bruce Lehman and the IIPI HIV/AIDS proposal |
 | | Lehman did not explain is that the UK or the USA could authorize parallel imports of Glaxo's 3TC, sold in different countries, including, for example, the version that Glaxo sells for $114.42 in India, where Glaxo competes against CIPLA drug (which sells for $46.51). |
 | | Lehman seems to favor (discounts for poor countries), because of the geographic boundaries of the licenses (TRIPS Article 31.f), and they seem to be a less trade restrictive practice than banning international exhaustion of rights (banning parallel imports), which Mr. |
 | | Lehman's version of a "digital agenda" was eventually rejected at a 1996 WIPO treaty, in favor of an alternative and more balanced proposal that was offered by African countries and backed by a large coalition of consumer, library and academic groups, and computer, internet and telecommunications businesses. |
| lists.essential.org /pharm-policy/msg00202.html (999 words) |
|